Regeneron Pharmaceuticals (REGN) Gets A Fresh Look As Trial Wins And Sanofi Deal Feed Value Narrative
Simply Wall Street
2026-10-10T23:30:16Z
$276.47 (1.49%)
Look this symbol up in Slack with /ticker ABBV. How to get stock tickers in Slack.
About AbbVie Inc
Healthcare
Loading chart…
Key Data
OPEN
$271.53
DAY RANGE
$270.38 - $277.6
52 WEEK RANGE
$189.4 - $277.6
MARKET CAP
$488554922000
VOLUME
4297946
AVERAGE VOLUME
Performance
Trade Day Range
$270.38
LOW
$277.6
HIGH
52 Week Range
$189.4
LOW
$277.6
HIGH
Trade Now
Using this link to sign up for Robinhood
Using this link to sign up for M1 Finance
Or this link to sign up for WeBull
Recent News
AbbVie's Experimental Cancer Drug Temab-A Earns Two FDA Breakthrough Designations for Advanced Colorectal and Lung Cancers
Medical Daily
2026-10-10T17:50:18Z
Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV) and Alkermes (ALKS)
The Globe and Mail
2026-10-10T13:17:21Z
Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV) and Alkermes (ALKS)
The Globe and Mail
2026-10-10T13:17:21Z
AbbVie stock trades 0.90 percent above its Xetra close of EUR 244.40 in weekend trading
AD HOC NEWS
2026-10-10T08:17:35Z
What Does AbbVie (ABBV) Winning Two FDA Breakthrough Tags Mean For Its Oncology Pipeline?
Yahoo! Finance Canada
2026-10-10T02:11:00Z
AbbVie Inc. stock underperforms Friday when compared to competitors despite daily gains
MarketWatch
2026-10-09T20:31:00Z
Get ABBV quotes in Slack with /ticker ABBV.
